060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2019-04, Vol.58 (Supplement_3)
Main Authors: Smolen, J S, Cohen, S, Emery, P, Rigby, W, Tanaka, Y, Zhang, Y, Friedman, A, Othman, A A, Camp, H S, Pangan, A L
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/kez106.059